Engin Kelkitli

Prof. Engin Kelkitli is a Professor at Ondokuz Mayıs University, Faculty of Medicine, Department of Internal Medicine since 2022. Previously, he served as Associate Professor (2015-2022) and Assistant Professor (2014-2015) at the same institution. His academic career is complemented by clinical experience as a hematologist with expertise in multiple myeloma, lymphoma, and stem cell transplantation.

Dr. Kelkitli completed his undergraduate medical education at Ondokuz Mayıs University Faculty of Medicine (1992-1998) followed by a post-doctorate in Medicine at the same institution (2009-2012). His professional journey includes clinical positions at various hospitals including Erzurum Bölge Eğitim ve Araştırma Hastanesi as a Hematology Specialist (2013-2014) and Sinop Durağan Devlet Hastanesi as an Internal Medicine Specialist and Chief Physician (2004-2013).

Dr. Kelkitli's research focuses on hematological malignancies, particularly multiple myeloma, lymphoma, and stem cell transplantation. His work examines prognostic factors, treatment outcomes, and novel therapeutic approaches in these conditions. He has made significant contributions to understanding the impact of various biomarkers on disease progression and response to treatment in hematological disorders.

His publication record demonstrates a strong focus on clinical hematology research with emphasis on multiple myeloma, lymphoma subtypes, stem cell transplantation outcomes, and management of complications in hematological malignancies. His recent work includes studies on CAR-T cell therapy in multiple myeloma, real-world data on chronic myeloid leukemia treatment, and investigations into prognostic markers in various hematological disorders.

Dr. Kelkitli has supervised five theses at the expertise level, mentoring students including A.NUR, O.ŞAHİN, Ö.YILMAZ, E.ARSLAN, and M.BATMACI. His research has been supported by institutional and possibly national grants, though specific grant details are not provided in the available information.

He has contributed to the academic community through book chapters on hematology topics including Castleman Disease, Myelodysplastic Syndromes, and various aspects of emergency hematology medicine. His work spans both clinical research and educational contributions to the field of hematology.